PL2399911T3 - Polimorfy febuksostatu - Google Patents

Polimorfy febuksostatu

Info

Publication number
PL2399911T3
PL2399911T3 PL10167344T PL10167344T PL2399911T3 PL 2399911 T3 PL2399911 T3 PL 2399911T3 PL 10167344 T PL10167344 T PL 10167344T PL 10167344 T PL10167344 T PL 10167344T PL 2399911 T3 PL2399911 T3 PL 2399911T3
Authority
PL
Poland
Prior art keywords
febuxostat
polymorphs
Prior art date
Application number
PL10167344T
Other languages
English (en)
Inventor
Ulrich Griesser
Verena Adamer
Andreas Hotter
Christoph Langes
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43033242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2399911(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL2399911T3 publication Critical patent/PL2399911T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PL10167344T 2010-06-25 2010-06-25 Polimorfy febuksostatu PL2399911T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10167344.0A EP2399911B1 (en) 2010-06-25 2010-06-25 Polymorphs of Febuxostat

Publications (1)

Publication Number Publication Date
PL2399911T3 true PL2399911T3 (pl) 2016-01-29

Family

ID=43033242

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10167344T PL2399911T3 (pl) 2010-06-25 2010-06-25 Polimorfy febuksostatu
PL11727454T PL2585445T3 (pl) 2010-06-25 2011-06-24 Polimorfy aktywnego składnika farmaceutycznego

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11727454T PL2585445T3 (pl) 2010-06-25 2011-06-24 Polimorfy aktywnego składnika farmaceutycznego

Country Status (7)

Country Link
US (1) US8946441B2 (pl)
EP (3) EP2399911B1 (pl)
CA (1) CA2802937C (pl)
DK (2) DK2399911T3 (pl)
ES (2) ES2553584T3 (pl)
PL (2) PL2399911T3 (pl)
WO (1) WO2011161245A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2553584T3 (es) 2010-06-25 2015-12-10 Sandoz Ag Polimorfos de Febuxostat
CN103396378B (zh) * 2013-07-29 2015-06-10 杭州朱养心药业有限公司 非布司他结晶
CZ27857U1 (cs) 2014-12-12 2015-02-23 Zentiva, K.S. Formulace obsahující tuhý roztok febuxostatu

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69941672D1 (de) * 1998-06-19 2010-01-07 Teijin Ltd Polymorphe modifikationen der 2-(3-cyano-4-isobutylphenyl)-4-methyl-5-thiazol-carbonsäure und verfahren zu ihrer herstellung
CN101836978B (zh) 2002-03-28 2013-09-11 帝人制药株式会社 含有单一晶型的固体制剂
EP2532654A1 (en) 2009-06-10 2012-12-12 Teva Pharmaceutical Industries Ltd. Crystalline forms of febuxostat
CN101648926B (zh) 2009-07-09 2011-11-16 石药集团欧意药业有限公司 一种非布司他晶型及其制备方法
CN101817801A (zh) * 2009-08-12 2010-09-01 北京红惠新医药科技有限公司 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸新晶型k及其他晶型的制备方法
ES2553584T3 (es) * 2010-06-25 2015-12-10 Sandoz Ag Polimorfos de Febuxostat

Also Published As

Publication number Publication date
EP2399911B1 (en) 2015-08-19
EP2399911A1 (en) 2011-12-28
ES2553584T3 (es) 2015-12-10
ES2553574T3 (es) 2015-12-10
EP2977372A1 (en) 2016-01-27
WO2011161245A2 (en) 2011-12-29
US20130137734A1 (en) 2013-05-30
DK2399911T3 (en) 2015-09-07
US8946441B2 (en) 2015-02-03
EP2585445A2 (en) 2013-05-01
PL2585445T3 (pl) 2016-01-29
CA2802937C (en) 2020-02-25
CA2802937A1 (en) 2011-12-29
EP2585445B1 (en) 2015-08-19
EP2977372B1 (en) 2019-05-08
DK2585445T3 (en) 2015-09-07
WO2011161245A3 (en) 2012-03-08

Similar Documents

Publication Publication Date Title
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
IL246900A0 (en) Polymorphs of Dronir
HK1204604A1 (en) Stereoselective total synthesis of noribogaine
IL221170A0 (en) Processes of synthesizing dihydropyridophthalazinone derivatives
IL222900A (en) Forms of Rifaximin
EP2513116A4 (en) POLYMORPH OF DARUNAVIR
ZA201300776B (en) Improved process for the preparation of febuxostat
ZA201209620B (en) Polymorphs of osi-906
EP2563768A4 (en) MANUFACTURE OF FEBUXOSTAT
GB201004096D0 (en) Production of polyhydroalkanoates
EP2800747A4 (en) POLYMORPHY OF PERAMPANEL
EP2524296A4 (en) EXTENDING THE VISUALIZATION FUNCTIONALITY OF AN APPLICATION
IL222474A0 (en) Method of synthesis
IL226041A0 (en) Polymorphic forms of pebuxostat
IL223926A0 (en) Synthesis of cyclopentaquinazolines
EP2680843A4 (en) DERIVATIVES OF PYRAZOLSUBSTITUTED AMINO-HETEROARYL COMPOUNDS
EP2619191A4 (en) NEW POLYMORPHS OF FEBUXOSTAT
PL2399911T3 (pl) Polimorfy febuksostatu
GB201008877D0 (en) Biolgical control of molluscs
EP2393786A4 (en) NEW POLYMORPHIC FROM LOPINAVIR
HK1160777A1 (en) Novel use of neohesperidoside
TWM386182U (en) Improved structure of seal
IL243320A0 (en) Intermediates of teroarylpiperidine and piperazine derivatives
IL214275A0 (en) Polymorphs of darunavir
IL233446A0 (en) Polymorphic forms of paramphenel